This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Science Daily - Heart Disease
MARCH 5, 2025
Research shows that a common type of diabetes medication could help cancer patients make a better long-term recovery. Many cancer patients go on to develop heart failure -- because of the cancer itself and also due to chemotherapy.
99 
Med Page Today
JULY 5, 2024
(MedPage Today) -- GLP-1 receptor agonists lowered the risk of several obesity-associated cancers, a retrospective analysis of electronic health records suggested. Compared with insulin, GLP-1s were associated with a lower risk for developing.
116 
Med Page Today
DECEMBER 7, 2023
(MedPage Today) -- Taking glucagon-like peptide 1 (GLP-1) receptor agonists for type 2 diabetes was associated with greater reductions in colorectal cancer (CRC) risk compared with several other diabetes medication classes, a nationwide cohort.
95 
Medical Xpress - Cardiology
MARCH 6, 2025
A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research from the University of East Anglia.
78 
Med Page Today
APRIL 10, 2024
(MedPage Today) -- A Scandinavian cohort study suggested a popular class of diabetes drug did not put patients at an elevated risk for thyroid cancer, a longtime lingering concern with this drug class. Compared with DPP-4 inhibitors, patients.
124 
Med Page Today
JANUARY 23, 2025
(MedPage Today) -- More thyroid cancers were detected soon after starting a GLP-1 receptor agonist than other diabetes drugs, a secondary analysis of a target trial emulation of a comparative effectiveness study found. Of over 350,000 adults with.
111 
HCPLive
JANUARY 24, 2025
GLP-1 RA initiation boosted new thyroid cancer diagnoses, compared with other anti-diabetic drugs, but enhanced early detection may have played a role.
104 
Med Page Today
FEBRUARY 3, 2024
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.
115 
HCPLive
FEBRUARY 8, 2024
A new study found balance and falling were linked to an increased risk of all-cause mortality, as well as cause-specific mortality from cardiovascular disease and diabetes.
Cardiometabolic Health Congress
JANUARY 30, 2024
Dr. Hallberg passed in March of 2022 after a 5-year battle with stage IV lung cancer. As an expert on metabolic control and type 2 diabetes (T2D), Dr. Hallberg once gave a TedTalk titled Reversing Type 2 diabetes starts with ignoring the guidelines , which quickly accumulated 8.6
105 
Frontiers in Cardiovascular Medicine
DECEMBER 13, 2023
It has been shown that patients with cancer have a longer expected life duration, benefiting from advanced medical therapy. A growing number of studies have elucidated the association between cancer and CVD. Moreover, different types of cancer have distinct risks, which may increase the complexity of antithrombotic therapy.
Frontiers in Cardiovascular Medicine
FEBRUARY 12, 2025
Sensitivity analyses reconfirmed the robustness of the associations of CVD and hypertension with COPD severity among patients who excluded bronchiectasis, tuberculosis, lung cancer, pulmonary hypertension, pulmonary heart disease, and diabetes (P<0.05).ConclusionThe
52 
Journal of the American Heart Association
FEBRUARY 26, 2025
BackgroundThere existed bidirectional associations of cardiovascular disease (CVD) and type 2 diabetes (T2D) with cancer, partly attributed to their shared risk factors. This highlighted the significance of maintaining high CVH throughout the life span for the primary prevention of CVD, T2D, and cancer.
45 
Frontiers in Cardiovascular Medicine
FEBRUARY 27, 2024
Cancer and cardiovascular disease represent the two leading causes of morbidity and mortality worldwide. However, this comes at a cost with more women developing diabetes, hypertension and coronary artery disease as they age. Women continue to enjoy a greater life expectancy than men.
NEJM Journal Watch - Cardiology
OCTOBER 15, 2024
An observational study suggests a protective association in patients with diabetes.
69 
Journal of the American Heart Association
DECEMBER 12, 2023
BackgroundPostpancreatectomy diabetes can be caused by resection of functioning pancreatic tissue and is associated with postoperative pancreatic islet cell mass loss and subsequent endocrine dysfunction. Diabetes is a well‐known risk factor for ischemic heart disease. Journal of the American Heart Association, Ahead of Print.
HCPLive
MARCH 19, 2024
The biosimilar recombinant human growth hormone, somatropin, was found to be well-tolerated; only 1.6% of pediatric patients had adverse events suspected to be caused by the injection.
59 
Heart BMJ
APRIL 15, 2024
Methods Participants with human epidermal growth factor receptor 2-positive breast cancer treated with trastuzumab±anthracycline ≥5 years previously were identified from a clinical database. mmol/L and 5% had a new diagnosis of diabetes. All participants had normal LVEF prior to, and on completion of, treatment.
52 
CardiacWire
SEPTEMBER 27, 2024
Better treatments have led to improved cancer survival rates, but new research reveals increased cardiovascular complications in survivors. However, another new study offers hope, suggesting that heart medications like SGLT2 inhibitors may help prevent cancer-related heart disease. smoking) and cancer-induced risk factors (e.g.
59 
Journal of the American Heart Association
MARCH 19, 2025
BackgroundCardiotoxicity in patients with cancer treated with anthracyclines is associated with increased morbidity and mortality. Hypertension, diabetes, hyperlipidemia, obesity, and low socioeconomic status were more common in NH Black and Hispanic individuals. Journal of the American Heart Association, Ahead of Print. NH Black, 38.5%
40 
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Type 2 Diabetes Mellitus (T2DM) is a rapidly growing global health problem with increasing prevalence. Of those patients, 35.43% (n=273,993) were diabetic and 64.57% (n=151,112) were non‐diabetic. Diabetics were more likely to be younger (70.43 Among diabetics, readmitted patients were more likely to be older (71.87
40 
ECG Cases
JULY 30, 2024
Compassion in not simply innate; like any behaviour, it can be learned through deliberate practice.
52 
Dr. Paddy Barrett
FEBRUARY 13, 2024
A 10 to 15kg weight loss in those who are overweight can reverse diabetes in 57% of patients with diabetes 1. Even in diabetics of normal weight (BMI<27), weight loss can reverse diabetes 2. 2 1184-P: Return to Normal Glucose Control by Weight Loss in Nonobese People with Type 2 Diabetes: The ReTUNE Study.
105 
CardiacWire
AUGUST 18, 2024
Half of the 10 meds in the ‘Class of 2026’ treat cardiovascular conditions, and these heart drugs saw some of the largest reductions: Novartis’ HF drug Entresto (-53% to $295) BMS’ anticoagulant Eliquis (-56% to $231) Janssen’s anticoagulant Xarelto (-62% to $197) BI/Lilly’s HF and diabetes drug Jardiance (-66% to $197) AstraZeneca’s HF, diabetes, (..)
59 
Frontiers in Cardiovascular Medicine
NOVEMBER 19, 2024
MethodsThis prospective cohort study included 43,735 participants, who participated in three consecutive health examinations in 2006, 2008, 2010 and had no history of CMD or cancer. Moreover, cum NHHR was positively correlated with the absolute risk of CMD, cardiovascular diseases (CVD), and type 2 diabetes (T2DM).ConclusionsHigher
59 
DAIC
FEBRUARY 29, 2024
12:15 p.m. 12:15 p.m.
103 
Hypertension Journal
DECEMBER 7, 2023
ETs were shown to play important roles among others, in systemic hypertension, particularly when resistant or difficult to control, and in pulmonary hypertension, atherosclerosis, cardiac hypertrophy, subarachnoid hemorrhage, chronic kidney disease, diabetic cardiovascular disease, scleroderma, some cancers, etc.
Physiologically Speaking
DECEMBER 27, 2023
The throng of epidemiological evidence hasn’t helped either — one week “butter is back” and the next, red meat is giving us diabetes. These gene-nutrient interactions influence things like the microbiome and gene expression, thereby influencing our risk for diseases like obesity, diabetes, and cardiovascular disease.
69 
CardiacWire
APRIL 10, 2024
GLP-1s Are So Hot Right Now – In the year since ACC 2023, GLP-1s went from a weight loss and diabetes drug that “might” have cardiovascular benefits to becoming a promising (and Medicare-covered) option for CV event reduction.
59 
Frontiers in Cardiovascular Medicine
FEBRUARY 13, 2024
After adjustment for potential confounders (age, race, marital status, socioeconomic status, lifestyle level, smoking status, cardiovascular disease, hypertension, diabetes and cancer), the men: women hazard ratios (HRs) for all-cause and cardiovascular mortality were 1.58 [95% Confidence Interval (CI): 1.48–1.68]
Dr. Smith's ECG Blog
SEPTEMBER 25, 2024
A 56 year old male with a history of diabetes, dyslipidemia, hypertension, and coronary artery disease presented to the emergency department with sudden onset weakness, fatigue, lethargy, and confusion. This is another case sent by the undergraduate (who is applying to med school) who works as an EKG tech. No ECG was ordered on Day #1.
120 
Physiologically Speaking
DECEMBER 27, 2023
The throng of epidemiological evidence hasn’t helped either — one week “butter is back” and the next, red meat is giving us diabetes. These gene-nutrient interactions influence things like the microbiome and gene expression, thereby influencing our risk for diseases like obesity, diabetes, and cardiovascular disease.
52 
Circulation
NOVEMBER 11, 2024
17.4]) and was also more likely to have diabetes mellitus, hyperlipidemia, chronic lung disease, chronic kidney disease, chronic liver disease, BMI ≥ 25, anemia, metastatic cancer, and atrial fibrillation. The hemophilia cohort was slightly older (63.2[16.8]
40 
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Family: Diabetes mellitus, gastric cancer, COVID. IntroductionOphtalmic dural arteriovenous fistula is not a common diagnosis. They usually present as subarachnoid hemorrhage, or parenquimatous hemorrhage as in our patient. Male, 46 years old, electric worker, right‐handed. Tobacco, Marihuana and alcohol positive.
40 
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Examination revealed right INO, skew deviation with right hypertropia, left lower extremity weakness, left upper extremity dysmetria, right facial weakness (prior deficit), and ataxic gait.
40 
Physiologically Speaking
OCTOBER 9, 2024
This could make LaKe an attractive option for weight management or as part of a dietary intervention for metabolic disorders like obesity and type 2 diabetes. Lac-Phe has been shown to suppress appetite in preclinical models. Physiologically Speaking is a reader-supported publication.
75 
Dr. Paddy Barrett
FEBRUARY 21, 2025
The reason excess weight is such big issues are the health consequences it confers with increased rates of diabetes, heart disease, osteoarthritis, obstructive sleep apnea, non-alcoholic fatty liver disease and others, just to name a few. Avoiding diabetes and its precursor states inclduing insulin resistance is key. NEJM Nov 13 2024
81 
Physiologically Speaking
MAY 1, 2024
This dietary approach has been studied for weight loss, metabolic syndrome, type 2 diabetes, epilepsy, Alzheimer’s disease, and cancer. Ketogenic diets are characterized as being very low in carbohydrates (less than 50 grams per day), modest in protein, and high in fat (more than 80% of total energy intake).
52 
Physiologically Speaking
MARCH 8, 2024
Poor sleep quantity and quality are widespread modifiable risk factors for several diseases, namely, cardiovascular disease, type 2 diabetes, and cancer. Modern society is plagued by a chronic sleep debt. Acute sleep loss is also insidious. It makes us less productive and more prone to automobile accidents.
52 
Dr. Paddy Barrett
OCTOBER 11, 2024
Obesity is the second leading cause of preventable cancers after smoking 9. Anything that reduces obesity has the potential to reduce future risks of any associated cancers. Colorectal Cancer - 46% reduction. Kidney Cancer - 24% reduction. Liver Cancer - 53% reduction. Pancreatic Cancer - 59% reduction.
85 
DAIC
FEBRUARY 14, 2025
Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes. For patients with no other options, amputation may become imminent.
Dr. Paddy Barrett
AUGUST 9, 2024
More than heart disease or cancer, the risk of dementia often creates much greater anxiety in the patients I see. Diabetes & Insulin Resistance Type 2 diabetes is when insulin resistance reaches the point where blood sugar levels can no longer be kept in range. J Diabetes Investig. But can dementia be prevented?
115 
Journal of Clinical Investigation - Cardiology
JULY 15, 2024
These circadian mechanisms represent potential pathophysiological pathways linking circadian disruption to adverse metabolic health outcomes, including obesity, metabolic syndrome, and type 2 diabetes.
111 
Medical Xpress - Cardiology
SEPTEMBER 12, 2024
A UCLA-led research team has found that a gene mutation that affects insulin signaling in the heart may raise the risk of deadly abnormal heart rhythms in a subset of patients with cancer and could have implications for those with diabetes and obesity.
79
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content